A
AZA	Azacitidine
ALCL	Anaplastic large cell lymphoma
ALL	Acute Lymphoblastic Leukemia
AML	Acute Myeloid Leukemia
ANKRD26	Ankyring Repeat Domain Containing protein 26
APL	Acute promyelocytic leukemia
ARF	Alternative Reading Frame
ASXL1	Additional Sex Combs-like 1
ATO	Arsenic trioxide
ATRA	All-trans retinoic acid
B
BCL-2	B-cell lymphoma-2
BCL-XL	B-cell lymphoma extra large
BCOR	BCL6 corepressor
BCORL1	BCL6 corepressor-like 1
BM	Bone Marrow
BRAF	V-Raf Murine Sarcoma Viral Oncogene Homolog B1
C
CAR	Chimeric Antigen Receptor
CBF	Core Binding Factor
CBL	Casitas B-lineage Lymphoma
CD	Cluster of Differentiation
CEBPA	CCAAT enhancer binding protein alpha
CH	Clonal Hematopoiesis
CNS	Central Nervous System
CR	Complete Remission
CRISPR	Clustered Regularly Interspaced Short Palindromic Repeats
CSF3R	Colony Stimulating Factor 3 receptor
D
DDX41	DEAD Box helicase 41
DNA	Deoxyribonucleic acid
DNMT3A	DNA (cytosine-5)-methyltransferase 3A
E
EFS	Event-Free Survival
ELN	European Leukemia Net
ETV6	ETS variant transcription factor 6
EZH2	Enhancer of Zeste Homolog 2
F
FAB	French–American–British Classification
FDA	Food and Drug Administration
FLT3-ITD	FMS-like tyrosine kinase 3 internal tandem duplication
FLT3-TKD	FMS-like tyrosine kinase 3 tyrosine kinase domain
FOXM1	Forkhead box M1
G
GATA2	GATA Binding protein 2
GPR56	G protein coupled receptor 56
GO	Gemtuzumab ozogamicin
H
HDAC	Histone Deacetylase
HiDAC	High-Dose Cytarabine
HLA	Human Leukocyte Antigen
HLF	Hepatic Leukemia Factor
HMA	Hypomethylating agent
HSCT	Hematopoietic Stem Cell Transplantation
HOX	Homeobox
I
ICC	International Consensus Classification
IDAC	Intermediate Dose Cytarabine
IDH1	Isocitrate Dehydrogenase 1
IDH 2	Isocitrate Dehydrogenase 2
IHC	Immunohistochemistry
J
JAK2	Janus Kinase 2
K
KMT2A	Lysine Methyltransferase 2A
KIT	KIT protooncogene, receptor tyrosine kinase
KPT-330	Selinexor
KPT-8602	Eltaxenor
KO	Knockout
KO-539	Ziftomenib
KRAS	Kirsten rat sarcoma viral oncogene homolog
M
MDS	Myelodysplastic Syndrome
MCL1	Myeloid Cell Leukemia sequence 1
MEIS1	Myeloid Ecotropic viral Integration site 1
MEIS-SMC4	Myeloid Ecotropic viral Integration site 1-Structural Maintenance of Chromosome 4
MLL	Mixed Lineage Leukemia
MPNs	Myeloproliferative Neoplasms
MRGs	Myelodysplasia related gene mutations
MRD	Measurable Residual Disease
MRD-LL	Measurable Residual Disease at Low Level
N
NCCN	National Comprehensive Cancer Network
ND	Newly Diagnosed
NF1	Neurofibromatosis type 1
NGS	Next-Generation Sequencing
NHL	Non-Hodgkin lymphoma
NK	Natural Killer
NPM1	Nucleophosmin 1
NPM1wt	NPM1 wild type
NRAS	Neuroblastoma RAS viral oncogene homolog
O
ORR	Overall Response Rate
OS	Overall Survival
P
PB	Peripheral Blood
PBX3	Pre-B-cell leukemia transcription factor 3
PD-1	Programmed (Cell) Death 1
PD-L1	Programmed (Cell) Death Ligand 1
PFS	Progression-free survival
PHF6	Plant Homeodomain Finger Protein 6
PPM1D	Protein phosphatase magnesium-dependent 1 delta
PRC1	Polycomb repressive complex 1
PRC2	Polycomb repressive complex 2
PTPN11	Protein Tyrosine Phosphatase Non-Receptor Type 11
R
RNA	Ribonucleic acid
RP2D	Recommended phase 2 dose
R/R AML	Relapsed or refractory acute myeloid leukemia
RT-qPCR	Quantitative Reverse Transcription Polymerase Chain Reaction
RUNX1	Runt-related transcription factor 1
S
SETBP1	Set Binding Protein 1
SF3B1	Splicing Factor 3B Subunit 1
SINE	Selective Inhibitors of Nuclear Export
SNDX-5613	Revumenib
SRSF2	Serine/Arginine-rich Splicing Factor 2
STAG2	Stromal Antigen 2
STAT5	Signal transducer and activator of transcription 5
T
TCR	T-cell receptor
TET2	TET methylcytosine dioxygenase 2
TP53	Tumor Protein p53
U
U2AF1	U2 small nuclear RNA auxiliary factor 1
V
VAF	Varied Allele Frequency
VEN	Venetoclax
W
WHO	World Health Organization
WT1	Wilms Tumor 1
X
XPO1	Exportin 1
Z
ZRSR2	Zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2